MyDrHank Tirzepatide Review: Cost, Named Pharmacies & Honest Verdict (2026)

Every price MyDrHank advertises for compounded tirzepatide is an annual-prepay rate. Its product page says "From $240/month" and its signup funnel says "from $200" — but the month-to-month price is $349, and no page on the site displays that number. We pulled the figures from MyDrHank's own product catalog on 7 August 2026. If you are comparing "$240" against another provider's monthly rate, you are comparing a $2,883 up-front commitment against a month. Every fact here comes from the company's own published program.

What MyDrHank is

MyDrHank is a direct-to-consumer telehealth platform running GLP-1 alongside longevity, peptides and NAD+, sexual health, hair growth, and strength lines — six categories from one account. GLP-1 is its self-described "most popular treatment," but it is one shelf among several rather than the whole business. Earlier research recorded its operating entity as Dr. Hank, LLC; we could not reconfirm that name on the site as it stands today, so treat it as previously reported rather than currently verified.

Every advertised price is a prepay rate

This is the part worth slowing down for. MyDrHank's own product catalog prices compounded tirzepatide on four tiers:

Now compare that against what the company actually shows you. The product page displays "From $240". The GLP-1 signup funnel displays "from $200". Both are the bottom of that ladder — and the $349 month-to-month rate appears on no page at all. You reach it only by opening the tier selector and declining to prepay.

That is the difference between a price and a commitment. "$240/month" is not what a month costs at MyDrHank; it is what a year costs, divided by twelve, payable as $2,883 today. The same pattern runs through the rest of its catalog: injectable semaglutide is $259/month month-to-month (advertised from $178), and oral semaglutide is $249 (advertised from $171).

One figure we could not reconcile: the funnel's "from $200" matches no tier in the company's own catalog — not the yearly $240, not anything else. Treat it as a number to confirm in writing rather than one to plan around.

A correction to our own earlier review. A previous version of this page reported that MyDrHank's disclaimer cited a $200 price "no tier matches," and a later revision briefly treated $349 as a stale figure that had been withdrawn. Both were wrong. $349 is the current month-to-month rate; it was never withdrawn, it is simply never displayed.

What we could not confirm

Earlier research credited MyDrHank with naming three pharmacy partners — Dunklau Pharmacy Holdings, InnovaScript, and PCM Venture I Pharmacy — which would be a genuine transparency advantage over the vague "US-licensed pharmacy" language most compounded sellers use. We could not find any of those three names on the site today, in the rendered page or its underlying HTML. The product page says only that the drug is "compounded in an FDA-registered U.S. pharmacy," which is the generic formulation. We are not calling the earlier finding wrong — pages change — but we will not carry a disclosure credit we cannot currently see, so this is no longer a reason to pick them.

Where it will not ship

MyDrHank's own affiliate disclosures list six states it excludes: Kansas, Louisiana, Mississippi, New Mexico, North Dakota, and West Virginia. The consumer-facing pages do not publish a served-states list, so this is the more complete picture of coverage.

The brand-vs-compounded question

MyDrHank dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

The genuine strengths, confirmed on the site today: free consultation, free delivery, no insurance required, cancel anytime, and — unusually for this category — an explicit written promise that the price does not rise as your dose escalates. That last one is worth more than it sounds. Dose-indexed pricing is one of the most common ways a cheap-looking GLP-1 plan becomes expensive by month four, and a provider willing to rule it out in writing is answering the right question. The trade-offs: every advertised price is a prepay rate and the $349 month-to-month figure is shown nowhere; a pharmacy disclosure we could not reconfirm; six excluded states you will only find in the affiliate terms; GLP-1 is one of six product lines rather than the platform's focus; and no money-back guarantee or refund window is disclosed anywhere we could find. Whatever you are quoted, get it in writing before paying; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

At $349/month month-to-month, MyDrHank is not the bargain its own pages imply — it sits above the median for compounded tirzepatide, and only the annual prepay brings it back to the middle of the field. The written promise that your dose will not change your price is real and worth something, because dose-indexed pricing is how a cheap first month becomes an expensive fourth one. But it is a promise about one axis of a price that is being presented misleadingly on another. Add the pharmacy disclosure that is no longer visible and an excluded-state list that lives in affiliate terms rather than anywhere a patient would read, and the pattern is a company that publishes its best number everywhere and its real one nowhere. Confirm your tier, your total, and your state in writing before paying. If you want a single itemized ladder that does not move depending on where you entered, compare it against bmiMD; if a checkable trust badge matters more, see AbundRX; for the broadest confirmed brand-name lineup, weigh altRX too. And speaking of disclosed addresses worth a second look, see our Ascend Vitality review — its Sheridan, WY suite is a known shared mail-drop location. See our best tirzepatide providers ranking for the full field.